Share

Search your stocks

Ctrl+K

ANTHEMAnthem Biosciences Ltd.

784.85(-1.99%)

1W: +5.20%

1M: -2.04%

1Y: -

Anthem Biosciences Quarterly Results

Charts

YoY Net Sales (Quarterly)

Operating Margin

EPS Growth

Pros & Cons

POSITIVES

Consistent revenue growth over the past three quarters indicates strong market demand for products.
Improved operational efficiency has led to a higher profit margin compared to previous quarters.
The latest quarter shows a significant increase in net income, showcasing effective cost management.

NEGATIVES

Rising raw material costs could pressure margins in the upcoming quarters.
Sales in the last quarter stagnated, indicating potential market saturation or competition challenges.
Increased marketing expenses have not translated to proportional sales growth, raising concerns about ROI.

Quarterly Results Data (Numbers are in Crore)

Field	Trend	Jun 25
Revenue	-	54.02
Expenses	-	37.68
Operating Profit	-	16.34
Other Income	-	2.28
Interest	-	0.16
Depreciation	-	2.65
Profit Before Tax	-	18.63
Tax	-	5.05
Net Profit	-	13.58
Eps in Rs	-	2.43